Business Description
Cannapharmarx Inc
NAICS : 325412
SIC : 2834
ISIN : US13765D1090
Total Employee Number:
26Description
Cannapharmarx Inc specializes in the acquisition, development, and operation of cannabis cultivation facilities in Canada. The group evolved to focus on producing medical cannabis and craft products. The products of the company are Unique Genetics, Craft Products, and Medical Cannabis.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | -4.47 | |||||
Debt-to-Equity | -0.67 | |||||
Debt-to-EBITDA | -2.37 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -32.62 | |||||
Beneish M-Score | -6.65 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 22.6 | |||||
3-Year EPS without NRI Growth Rate | 26.7 | |||||
3-Year FCF Growth Rate | 47.7 | |||||
3-Year Book Growth Rate | 14.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 78.97 | |||||
9-Day RSI | 70.6 | |||||
14-Day RSI | 62.45 | |||||
3-1 Month Momentum % | -43.24 | |||||
6-1 Month Momentum % | -56.25 | |||||
12-1 Month Momentum % | -30 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.04 | |||||
Days Inventory | 119.09 | |||||
Days Sales Outstanding | 37.81 | |||||
Days Payable | 847.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -34.2 | |||||
Shareholder Yield % | -282.63 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -88.76 | |||||
Operating Margin % | -170.16 | |||||
Net Margin % | -666.22 | |||||
EBITDA Margin % | -512.83 | |||||
FCF Margin % | -6.65 | |||||
OCF Margin % | -6.65 | |||||
ROA % | -129.86 | |||||
ROIC % | -11.43 | |||||
3-Year ROIIC % | 21.24 | |||||
ROC (Joel Greenblatt) % | -153.93 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.2 | |||||
Price-to-Free-Cash-Flow | 2.4 | |||||
Price-to-Operating-Cash-Flow | 2.4 | |||||
EV-to-EBIT | -2.64 | |||||
EV-to-EBITDA | -2.64 | |||||
EV-to-Revenue | 13.52 | |||||
EV-to-FCF | -203.21 | |||||
Earnings Yield (Greenblatt) % | -37.88 | |||||
FCF Yield % | -6.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CPMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cannapharmarx Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.699 | ||
| EPS (TTM) ($) | -0.01 | ||
| Beta | -4589.8075 | ||
| 3-Year Sharpe Ratio | 0.4 | ||
| 3-Year Sortino Ratio | 2.75 | ||
| Volatility % | 92.63 | ||
| 14-Day RSI | 62.45 | ||
| 14-Day ATR ($) | 0.000244 | ||
| 20-Day SMA ($) | 0.001993 | ||
| 12-1 Month Momentum % | -30 | ||
| 52-Week Range ($) | 0.0003 - 0.01 | ||
| Shares Outstanding (Mil) | 708.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cannapharmarx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cannapharmarx Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 79 days | ||
| General meeting for 2025 | 2026-08-28 | In 2 days | ||
| Second quarter earnings results for 2026 | 2026-08-18 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-20 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-03-31 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 0.00 (-15.48%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-16 | 0.00 (+0.00%) | ||
| Annual report for 2024 | 2025-04-10 | 0.01 (+96.43%) | ||
| Third quarter earnings results for 2024 | 2024-11-13 | 0.01 (+6.38%) |
Show
Entries
Cannapharmarx Inc Frequently Asked Questions
What is Cannapharmarx Inc(CPMD)'s stock price today?
The current price of CPMD is $0.00. The 52 week high of CPMD is $0.01 and 52 week low is $0.00.
When is next earnings date of Cannapharmarx Inc(CPMD)?
The next earnings date of Cannapharmarx Inc(CPMD) is 2026-11-13 Est..
Does Cannapharmarx Inc(CPMD) pay dividends? If so, how much?
Cannapharmarx Inc(CPMD) does not pay dividend.
Press Release
Articles on Cannapharmarx Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers